http://stream.publicbroadcasting.net/production/mp3/wkyu/local-wkyu-820086.mp3
Nashville, TN – A one-of-a-kind partnership is taking place between Vanderbilt University and Johnson & Johnson that could change the way pharmaceutical drugs are produced. Normally, universities conduct general research and publish their findings in journals. Now, researchers at Vanderbilt are looking to discover new molecules that will lead to schizophrenia medications. Kevin Willis visited Vanderbilt University to meet the director of the school's drug discovery program.